MedTrace Logo

Surgical Intervention for the Treatment of Diabetes in Overweight Non-responders-1

NCT02610530 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2016-08-01

No results posted yet for this study

Summary

The SIT-DOWN study is a single centered retrospective study in which a total of 90 (ninety) participants who are overweight (BMI: 25-29.9 kg/m2) and have type 2 diabetes mellitus (T2DM) will be evaluated for the efficacy of surgical intervention in comparison with medical treatment. Primary endpoint of the study will be the change in glycemic regulation by the end of 12 months.

Conditions

Interventions

PROCEDURE

Sleeve Gastrectomy with Ileal Transposition

Type 2 diabetic patients who underwent ileal transposition surgery within the last 2 years.

PROCEDURE

Sleeve Gastrectomy with Transit Bipartition

Type 2 diabetic patients who underwent transit bipartition surgery within the last 2 years.

OTHER

Medical Treatment

Conventional Non-Surgical Treatment for Glycemic Control group consisted of patients who did not undergo any kind of surgery, and are on medical treatment for type 2 diabetes.

Sponsors & Collaborators

  • Turkish Metabolic Surgery Foundation

    lead OTHER

Principal Investigators

  • Alper Celik, MD · Turkish Metabolic Surgery Foundation

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-07-31
Completion
2016-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02610530 on ClinicalTrials.gov